| Name | larixyl acetate |
|---|---|
| Synonyms |
Larixylacetat
Larixol-monoacetat 6-Acetyllarixol |
| Description | Larixyl acetate is a potent and selective TRPC6 inhibitor with IC50 values of 0.58 μM and 6.83 μM against hTRPC6-YFP and hTRPC3-YFP, respectively. Larixyl acetate prevents HPV and is effective in protecting against traumatic brain injury-induced systemic endothelial dysfunction[1][2]. |
|---|---|
| Related Catalog | |
| Target |
hTRPC6:0.58 μM (IC50) hTRPC3:6.83 μM (IC50) |
| References |
| Density | 1.00±0.1 g/cm3 (20ºC 760 Torr) |
|---|---|
| Boiling Point | 419.3±28.0 °C |
| Melting Point | 82ºC |
| Molecular Formula | C22H36O3 |
| Molecular Weight | 348.51900 |
| Exact Mass | 348.26600 |
| PSA | 46.53000 |
| LogP | 5.04400 |
| Index of Refraction | 1.4826 (589.3 nm, 20℃) |
| Storage condition | ?20°C |
| RIDADR | NONH for all modes of transport |
|---|